PRESS RELEASE published on 11/06/2025 at 15:45, 10 months 16 days ago Form 8.3 - The Vanguard Group, Inc.: American Axle & Manufacturing Holdings, Inc. The Vanguard Group, Inc. discloses a 7.47% interest in American Axle & Manufacturing Holdings, Inc. through Form 8.3 filing on 06-Nov-2025 Form 8.3 Disclosure The Vanguard Group Interest American Axle & Manufacturing Holdings
BRIEF published on 11/06/2025 at 15:45, 10 months 16 days ago The Vanguard Group Discloses Position in Greencore Group plc Form 8.3 Vanguard Group Securities Position Equity Interests Greencore Group
PRESS RELEASE published on 11/06/2025 at 15:44, 10 months 16 days ago Form 8.3 - The Vanguard Group, Inc.: JTC plc The Vanguard Group, Inc. discloses a 5.06% interest in JTC plc's securities. Deals in 1p ordinary shares of JTC plc Securities Disclosure The Vanguard Group 1p Ordinary Shares JTC Plc
BRIEF published on 11/06/2025 at 15:43, 10 months 16 days ago The Vanguard Group Discloses Position in Bluefield Solar Income Fund Takeover Code Securities Disclosure Vanguard Group UK Regulation Bluefield Solar
PRESS RELEASE published on 11/06/2025 at 15:42, 10 months 16 days ago Form 8.3 - The Vanguard Group, Inc.: Avadel Pharmaceuticals plc The Vanguard Group, Inc. discloses 5.67% stake in Avadel Pharmaceuticals plc. Details of holdings and dealings reported under Rule 8.3 by Irish Takeover Panel Irish Takeover Panel Rule 8.3 Vanguard Group Financial Disclosure Avadel Pharmaceuticals
BRIEF published on 11/06/2025 at 15:42, 10 months 16 days ago The Vanguard Group Discloses Position in Spire Healthcare Group Securities Form 8.3 Takeover Code Vanguard Group Spire Healthcare
PRESS RELEASE published on 11/06/2025 at 15:41, 10 months 16 days ago Form 8.3 - The Vanguard Group, Inc.: Mural Oncology plc The Vanguard Group, Inc. discloses a 1.67% interest in Mural Oncology plc via Form 8.3 with details of securities holdings and transactions Securities Transactions Form 8.3 Vanguard Group Mural Oncology Plc
BRIEF published on 11/06/2025 at 15:41, 10 months 16 days ago The Vanguard Group Discloses Stake in Alphawave IP Group Ordinary Shares Takeover Code Vanguard Investment Disclosure Alphawave IP Group
PRESS RELEASE published on 11/06/2025 at 15:40, 10 months 16 days ago Form 8.3 - The Vanguard Group, Inc.: Greencore Group plc The Vanguard Group, Inc. discloses a 5.35% stake in Greencore Group plc. Additional disclosures include dealings with Bakkavor Group plc Disclosure The Vanguard Group Dealings Greencore Group Plc Bakkavor Group Plc
BRIEF published on 11/06/2025 at 15:39, 10 months 16 days ago The Vanguard Group Discloses Position on Dowlais Group and American Axle Takeover Code Securities Disclosure Vanguard Group Dowlais Group American Axle
Published on 09/22/2026 at 23:10, 48 minutes ago Global Atomic Announces Proposed Public Offering of Units
Published on 09/22/2026 at 22:30, 1 hour 28 minutes ago Silver Spruce Receives TSXV Conditional Approval of Debt Settlement
Published on 09/22/2026 at 22:01, 1 hour 57 minutes ago Fermi and TensorWave Agree to Extend Closing Date to October 31, 2026
Published on 09/22/2026 at 21:40, 2 hours 18 minutes ago Sekur Private Data Launches Sekur.com in Portuguese in Preparation for Angola Launch
Published on 09/22/2026 at 17:00, 6 hours 58 minutes ago Leggett Dynamics Expands Asia Pacific Headquarters
Published on 09/22/2026 at 19:40, 4 hours 17 minutes ago EQS-Adhoc: Pyrum Innovations AG: Revision of the Forecast for the Financial Year 2026
Published on 09/22/2026 at 19:00, 4 hours 58 minutes ago LLB focuses on its "elevate" strategy for growth, excellence and resilience
Published on 09/22/2026 at 18:30, 5 hours 28 minutes ago Avolta partners with Hawaii’s Department of Transportation to expand airport dining at three airports
Published on 09/22/2026 at 17:45, 6 hours 13 minutes ago Carvolix submits 510(k) for TAVIPILOT Robot, advancing toward US commercial launch of Its Integrated TAVIPILOT Platform.
Published on 09/22/2026 at 17:40, 6 hours 18 minutes ago VALBIOTIS SA: Valbiotis announces positive results from the Cardio-Liver clinical study - Commercial launch of ValbiotisPRO® Foie on September 23
Published on 09/22/2026 at 18:00, 5 hours 58 minutes ago Consolidated results for the first half of 2026 EBITDA : 60,5 M€
Published on 09/22/2026 at 17:45, 6 hours 13 minutes ago Imerys-09-2026-information-share-capital-and-voting-rights-as-of-31-August-2026
Published on 09/21/2026 at 18:19, 1 day 5 hours ago Reporting on share buyback transactions carried out between September 14 and September 18, 2026
Published on 09/21/2026 at 18:01, 1 day 5 hours ago Partnership agreement signed between Manitou Group and HD Construction Equipment
